Dealing with cancer screening in the COVID-19 era
Rev. Assoc. Med. Bras. (1992)
;
67(supl.1): 86-90, 2021. graf
Article
in English
| LILACS
| ID: biblio-1287865
ABSTRACT
SUMMARY OBJECTIVE: This article aims to alert health professionals for cancer screening in the face of the possibility of new waves of disease. METHODS: A narrative review was conducted through a search in MEDLINE, Lilacs, Chinese Biomedical Literature Database, and international medical societies publications. RESULTS: Breast cancer: in high-risk patients (confirmed familial cancer syndrome or with high-risk tools scores), clinicians should act according to usual recommendations; in average-risk individuals, consider screening with mammography with a longer time span (maximum of two years). Cervical cancer: women turning 25 years old who have already been immunized and with no previous Pap test can have the test postponed during the pandemic; if there is no previous dose of Human Papillomavirus vaccination, initiation of screening should be recommended following a more rigid approach for COVID prevention; in women over 30 years of age who have never participated in cervical screening, the first screening exam is also essential. Colorectal cancer: if the individual is at elevated risk for familial cancer, the screening with colonoscopy according to usual recommendations should be supported; if at average risk consider screening with Fecal Occult Blood Test. Prostate cancer: there is a trend to postpone routine prostate cancer screening until the pandemic subsides. CONCLUSIONS: The decision to keep cancer screening must be discussed and individualized, considering the possibility of new waves of COVID-19.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Prostatic Neoplasms
/
Colorectal Neoplasms
/
Uterine Cervical Neoplasms
/
Papillomavirus Infections
/
Papillomavirus Vaccines
/
COVID-19
Type of study:
Diagnostic study
/
Practice guideline
/
Prognostic study
/
Screening study
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
English
Journal:
Rev. Assoc. Med. Bras. (1992)
Year:
2021
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
BAHIANA Escola de Medicina e Saúde/BR
/
Núcleo de Oncologia da Bahia/BR
/
Universidade Federal da Bahia/BR
/
Universidade Federal de Minas Gerais/BR
Similar
MEDLINE
...
LILACS
LIS